AbbVie Inc. (ABBV) reported first-quarter 2025 adjusted earnings per share (EPS) of $2.46, which beat the Zacks Consensus Estimate of$2.39. The reported EPS also exceeded the company’s guidance of $2.34-$2.38 issued earlier this month. Earnings rose 6.5% year over year.ABBV’s revenues of $13.34 billion beat the Zacks Consensus Estimate of$12.91 billion. Sales rose 8.4% year over year on a reported basis and 9.8% on an operational basis. This reported figure also surpassed the company’s forecast of $12.8 b ...